Trials / Active Not Recruiting

Active Not RecruitingNCT04124406

Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and Mortality

Status: Active Not Recruiting
Phase: —
Study type: Observational
Enrollment: 150,000 (estimated)

Sponsor: Exact Sciences Corporation · Industry
Sex: All
Age: 18 Years
Healthy volunteers: Accepted

Summary

The purpose of this study is to gather information about the long term health of people who have been prescribed the Cologuard test, which is used for colorectal cancer (CRC) screening.

Detailed description

Participates will be consented for prospective follow-up for health outcomes, which will be ascertained through periodic contacts. Participants will complete a baseline health questionnaire survey (T0) and a 1-year follow-up questionnaire survey (T1), allow access to medical records, when available, and allow future contacts for additional surveys.

Conditions

Colon Cancer

Interventions

Type	Name	Description
DEVICE	Cologuard	multi-target stool Deoxyribonucleic Acid (MT-sDNA) screening test

Timeline

Start date: 2019-10-18
Primary completion: 2023-12-31
Completion: 2025-12-01
First posted: 2019-10-11
Last updated: 2025-10-03

Locations

1 site across 1 country: United States

Regulatory

FDA-regulated device study

Source: ClinicalTrials.gov record NCT04124406. Inclusion in this directory is not an endorsement.